Wei Zheng
Research Subjects
Wei Zheng has a total of 93 co-authors. Here are the top co-authors by number of shared publications:
Qingyun Xie
Department of Orthopaedics, The General Hospital of Western Theater Command, Chengdu, Sichuan 610083, China
6 shared publicationsWei Wang
Department of Orthopaedics, The General Hospital of Western Theater Command, Chengdu, Sichuan, 610083, China
5 shared publicationsJun Sheng
Department of Orthopedics, The General Hospital of Western Theater Command, Tianhui Road 270, Chengdu, 610000, People's Republic of China
4 shared publications- Qingyun Xie
Department of Orthopedics, The General Hospital of Western Theater Command PLA, Chengdu, 610083, China.
4 shared publications - Wei Wang
Department of Orthopedics, The General Hospital of Western Theater Command PLA, Chengdu, 610083, China.
4 shared publications Da Liu
Department of Orthopaedics, The General Hospital of Western Theater Command, Chengdu, Sichuan 610083, China
3 shared publications
Latest Publications
- Open Access
- 26 June 2026
- Published by Wiley in Advanced Science
- Vol. 13 (52) , e76293
REGγ Suppresses Ferroptosis and Induces Drug Resistance by Degrading WDR6 in Chondrosarcoma
Chondrosarcoma (CS) is a malignant bone tumor for which treatment efficacy remains clinically challenging owing to chemotherapy resistance. Ferroptosis, an iron‐dependent form of regulated cell death initiated by lipid peroxidation, has emerged as a promising strategy for addressing drug resistance. However, the potential of targeting ferroptosis to overcome drug resistance in CS has not been systematically elucidated. Our study identifies REGγ as a critical driver of malignant progression in chondrosarcoma, with its elevated expression correlating with unfavorable patient outcomes. Loss of REGγ potentiates lipid peroxidation and modulates the activation of ferroptosis‐associated genes by enhancing WDR6 protein stability. Mechanistically, REGγ degrades WDR6 through a ubiquitin‐independent mechanism, inhibiting the ferroptosis pathway governed by the STK11/AMPK axis and consequently promoting tumor drug resistance. Additionally, RLY01, an inhibitor of the REGγ‐20S proteasome, effectively suppresses chondrosarcoma growth and sensitizes chondrosarcoma cells to cisplatin. Collectively, REGγ emerges as a highly promising therapeutic target for improving the efficacy of cisplatin and other chemotherapies in CS.
- 26 June 2026
- Published by Wiley in Advanced Science
- Vol. 13 (52) , e76293
Open AccessREGγ Suppresses Ferroptosis and Induces Drug Resistance by Degrading WDR6 in Chondrosarcoma
Chondrosarcoma (CS) is a malignant bone tumor for which treatment efficacy remains clinically challenging owing to chemotherapy resistance. Ferroptosis, an iron‐dependent form of regulated cell death initiated by lipid peroxidation, has emerged as a promising strategy for addressing drug resistance. However, the potential of targeting ferroptosis to overcome drug resistance in CS has not been systematically elucidated. Our study identifies REGγ as a critical driver of malignant progression in chondrosarcoma, with its elevated expression correlating with unfavorable patient outcomes. Loss of REGγ potentiates lipid peroxidation and modulates the activation of ferroptosis‐associated genes by enhancing WDR6 protein stability. Mechanistically, REGγ degrades WDR6 through a ubiquitin‐independent mechanism, inhibiting the ferroptosis pathway governed by the STK11/AMPK axis and consequently promoting tumor drug resistance. Additionally, RLY01, an inhibitor of the REGγ‐20S proteasome, effectively suppresses chondrosarcoma growth and sensitizes chondrosarcoma cells to cisplatin. Collectively, REGγ emerges as a highly promising therapeutic target for improving the efficacy of cisplatin and other chemotherapies in CS.
- Open Access
- 22 April 2024
- Published by Springer Nature in BMC Medical Genomics
- Vol. 17 (1) , 1-15
Identification of osteoporosis ferroptosis-related markers and potential therapeutic compounds based on bioinformatics methods and molecular docking technology
Research background and purpose: Osteoporosis (OP) is one of the most common bone diseases worldwide, characterized by low bone mineral density and susceptibility to pathological fractures, especially in postmenopausal women and elderly men. Ferroptosis is one of the newly discovered forms of cell death regulated by genes in recent years. Many studies have shown that ferroptosis is closely related to many diseases. However, there are few studies on ferroptosis in osteoporosis, and the mechanism of ferroptosis in osteoporosis is still unclear. This study aims to identify biomarkers related to osteoporosis ferroptosis from the GEO (Gene Expression Omnibus) database through bioinformatics technology, and to mine potential therapeutic small molecule compounds through molecular docking technology, trying to provide a basis for the diagnosis and treatment of osteoporosis in the future. Materials and methods: We downloaded the ferroptosis-related gene set from the FerrDb database (http://www.zhounan.org/ferrdb/index.html), downloaded the data sets GSE56815 and GSE7429 from the GEO database, and used the R software “limma” package to screen differentially expressed genes (DEGs) from GSE56815, and intersected with the ferroptosis gene set to obtain ferroptosis-related DEGs. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis were performed by the R software “clusterProfiler” package. The random forest model was further screened to obtain essential ferroptosis genes. R software “corrplot” package was used for correlation analysis of essential ferroptosis genes, and the Wilcox test was used for significance analysis. The lncRNA-miRNA-mRNA-TF regulatory network was constructed using Cytoscape software. The least absolute shrinkage and selection operator (LASSO) was used to construct a disease diagnosis model, and a Receiver operating characteristic (ROC) curve was drawn to evaluate the diagnostic performance, and then GSE7429 was used to verify the reliability of the diagnosis model. Molecular docking technology was used to screen potential small molecule compounds from the Drugbank database. Finally, a rat osteoporosis model was constructed, and peripheral blood mononuclear cells were extracted for qRT-PCR detection to verify the mRNA expression levels of crucial ferroptosis genes. Result: Six DEGs related to ferroptosis were initially screened out. GO function and KEGG pathway enrichment analysis showed that ferroptosis-related DEGs were mainly enriched in signaling pathways such as maintenance of iron ion homeostasis, copper ion binding function, and ferroptosis. The random forest model identified five key ferroptosis genes, including CP, FLT3, HAMP, HMOX1, and SLC2A3. Gene correlation analysis found a relatively low correlation between these five key ferroptosis genes. The lncRNA-miRNA-mRNA-TF regulatory network shows that BAZ1B and STAT3 may also be potential molecules. The ROC curve of the disease diagnosis model shows that the model has a good diagnostic performance. Molecular docking technology screened out three small molecule compounds, including NADH, Midostaurin, and Nintedanib small molecule compounds. qRT-PCR detection confirmed the differential expression of CP, FLT3, HAMP, HMOX1 and SLC2A3 between OP and normal control group. Conclusion: This study identified five key ferroptosis genes (CP, FLT3, HAMP, HMOX1, and SLC2A3), they were most likely related to OP ferroptosis. In addition, we found that the small molecule compounds of NADH, Midostaurin, and Nintedanib had good docking scores with these five key ferroptosis genes. These findings may provide new clues for the early diagnosis and treatment of osteoporosis in the future.
- 22 April 2024
- Published by Springer Nature in BMC Medical Genomics
- Vol. 17 (1) , 1-15
Open AccessIdentification of osteoporosis ferroptosis-related markers and potential therapeutic compounds based on bioinformatics methods and molecular docking technology
Research background and purpose: Osteoporosis (OP) is one of the most common bone diseases worldwide, characterized by low bone mineral density and susceptibility to pathological fractures, especially in postmenopausal women and elderly men. Ferroptosis is one of the newly discovered forms of cell death regulated by genes in recent years. Many studies have shown that ferroptosis is closely related to many diseases. However, there are few studies on ferroptosis in osteoporosis, and the mechanism of ferroptosis in osteoporosis is still unclear. This study aims to identify biomarkers related to osteoporosis ferroptosis from the GEO (Gene Expression Omnibus) database through bioinformatics technology, and to mine potential therapeutic small molecule compounds through molecular docking technology, trying to provide a basis for the diagnosis and treatment of osteoporosis in the future. Materials and methods: We downloaded the ferroptosis-related gene set from the FerrDb database (http://www.zhounan.org/ferrdb/index.html), downloaded the data sets GSE56815 and GSE7429 from the GEO database, and used the R software “limma” package to screen differentially expressed genes (DEGs) from GSE56815, and intersected with the ferroptosis gene set to obtain ferroptosis-related DEGs. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analysis were performed by the R software “clusterProfiler” package. The random forest model was further screened to obtain essential ferroptosis genes. R software “corrplot” package was used for correlation analysis of essential ferroptosis genes, and the Wilcox test was used for significance analysis. The lncRNA-miRNA-mRNA-TF regulatory network was constructed using Cytoscape software. The least absolute shrinkage and selection operator (LASSO) was used to construct a disease diagnosis model, and a Receiver operating characteristic (ROC) curve was drawn to evaluate the diagnostic performance, and then GSE7429 was used to verify the reliability of the diagnosis model. Molecular docking technology was used to screen potential small molecule compounds from the Drugbank database. Finally, a rat osteoporosis model was constructed, and peripheral blood mononuclear cells were extracted for qRT-PCR detection to verify the mRNA expression levels of crucial ferroptosis genes. Result: Six DEGs related to ferroptosis were initially screened out. GO function and KEGG pathway enrichment analysis showed that ferroptosis-related DEGs were mainly enriched in signaling pathways such as maintenance of iron ion homeostasis, copper ion binding function, and ferroptosis. The random forest model identified five key ferroptosis genes, including CP, FLT3, HAMP, HMOX1, and SLC2A3. Gene correlation analysis found a relatively low correlation between these five key ferroptosis genes. The lncRNA-miRNA-mRNA-TF regulatory network shows that BAZ1B and STAT3 may also be potential molecules. The ROC curve of the disease diagnosis model shows that the model has a good diagnostic performance. Molecular docking technology screened out three small molecule compounds, including NADH, Midostaurin, and Nintedanib small molecule compounds. qRT-PCR detection confirmed the differential expression of CP, FLT3, HAMP, HMOX1 and SLC2A3 between OP and normal control group. Conclusion: This study identified five key ferroptosis genes (CP, FLT3, HAMP, HMOX1, and SLC2A3), they were most likely related to OP ferroptosis. In addition, we found that the small molecule compounds of NADH, Midostaurin, and Nintedanib had good docking scores with these five key ferroptosis genes. These findings may provide new clues for the early diagnosis and treatment of osteoporosis in the future.
- Open Access
- 17 March 2023
- Published by Elsevier in Journal of Clinical Densitometry
- Vol. 26 (2) , 101367
Research Advances in the Treatment of Bone Marrow Edema Syndrome
- 17 March 2023
- Published by Elsevier in Journal of Clinical Densitometry
- Vol. 26 (2) , 101367
Open AccessResearch Advances in the Treatment of Bone Marrow Edema Syndrome
- Open Access
- 19 April 2022
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 849076
Discovery of Potential Biomarkers for Postmenopausal Osteoporosis Based on Untargeted GC/LC-MS
Purpose: As an important public health problem, osteoporosis (OP) in China is also in an upward trend year by year. As a standard method for diagnosing OP, dual-energy X-ray absorptiometry (DXA) cannot analyze the pathological process but only see the results. It is difficult to evaluate the early diagnosis of OP. Our study was carried out through a serum metabolomic study of OP in Chinese postmenopausal women on untargeted gas chromatography (GC)/liquid chromatography (LC)–mass spectrometry (MS) to find possible diagnostic markers. Materials and Methods: 50 Chinese postmenopausal women with osteoporosis and 50 age-matched women were selected as normal controls. We first used untargeted GC/LC-MS to analyze the serum of these participants and then combined it with a large number of multivariate statistical analyses to analyze the data. Finally, based on a multidimensional analysis of the metabolites, the most critical metabolites were considered to be biomarkers of OP in postmenopausal women. Further, biomarkers identified relevant metabolic pathways, followed by a map of metabolic pathways found in the database. Results: We found that there may be metabolic pathway disorders like glucose metabolism, lipid metabolism, and amino acid metabolism in postmenopausal women with OP. 18 differential metabolites are considered to be potential biomarkers of OP in postmenopausal women which are a major factor in metabolism and bone physiological function. Conclusion: These findings can be applied to clinical work through further validation studies. It also shows that metabonomic analysis has great potential in the application of early diagnosis and recurrence monitoring in postmenopausal OP women.
- 19 April 2022
- Published by Frontiers Media SA in Frontiers in Endocrinology
- Vol. 13, 849076
Open AccessDiscovery of Potential Biomarkers for Postmenopausal Osteoporosis Based on Untargeted GC/LC-MS
Purpose: As an important public health problem, osteoporosis (OP) in China is also in an upward trend year by year. As a standard method for diagnosing OP, dual-energy X-ray absorptiometry (DXA) cannot analyze the pathological process but only see the results. It is difficult to evaluate the early diagnosis of OP. Our study was carried out through a serum metabolomic study of OP in Chinese postmenopausal women on untargeted gas chromatography (GC)/liquid chromatography (LC)–mass spectrometry (MS) to find possible diagnostic markers. Materials and Methods: 50 Chinese postmenopausal women with osteoporosis and 50 age-matched women were selected as normal controls. We first used untargeted GC/LC-MS to analyze the serum of these participants and then combined it with a large number of multivariate statistical analyses to analyze the data. Finally, based on a multidimensional analysis of the metabolites, the most critical metabolites were considered to be biomarkers of OP in postmenopausal women. Further, biomarkers identified relevant metabolic pathways, followed by a map of metabolic pathways found in the database. Results: We found that there may be metabolic pathway disorders like glucose metabolism, lipid metabolism, and amino acid metabolism in postmenopausal women with OP. 18 differential metabolites are considered to be potential biomarkers of OP in postmenopausal women which are a major factor in metabolism and bone physiological function. Conclusion: These findings can be applied to clinical work through further validation studies. It also shows that metabonomic analysis has great potential in the application of early diagnosis and recurrence monitoring in postmenopausal OP women.
- Open Access
- 7 September 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1
Author Correction: Development of a valid Chinese version of the Cumberland Ankle Instability Tool in Chinese-speaking patients with chronic ankle instability disorders
- 7 September 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1
Open AccessAuthor Correction: Development of a valid Chinese version of the Cumberland Ankle Instability Tool in Chinese-speaking patients with chronic ankle instability disorders
- 1 September 2021
- Vol. 52 (5) , 799-806
负载抗生素铜掺杂羟基磷灰石微球的制备及抗菌成骨评价
探讨负载万古霉素(vancomycin, Van)的铜(Cu)掺杂羟基磷灰石(hydroxyapatite, HA)微球制备方法,并于体外评价其抗菌及成骨作用。 采用水热合成法制备摩尔掺杂比例1%、5%、10%、20%的Cu掺杂HA微球(Cu-HA),通过扫描电镜观察其微观形貌变化,X射线衍射仪(X-ray diffractometer, XRD)研究其相组成并分析样品的结晶度。选择摩尔掺杂比例为10%的Cu-HA,利用X射线能谱仪(energy dispersive X-ray spectroscopy, EDS)分析样品的元素成分信息后,以聚多巴胺(polydopamine, PDA)为介质涂覆制备Cu-HA-PDA,采用XRD和傅里叶红外光谱仪检测样品涂覆效果。在Cu-HA-PDA装载Van,制备成Cu-HA-PDA-Van。将均为10 mg/mL的HA、Cu-HA、HA-PDA、Cu-HA-PDA-Van分别加入α培养基中制备各组浸提液,检测浸提液主要成分,检查Van质量浓度。探究材料浸提液对成骨前体细胞的毒性作用及骨髓间充质干细胞的增殖、分化作用,并检测成骨相关基因骨钙素(osteocalcin, OCN)、Runt相关转录因子2(runt-related transcription factor 2, RUNX-2)、碱性磷酸酶(alkaline phosphatase, ALP)表达。备好灭菌的HA、Cu-HA、HA-PDA、Cu-HA-PDA、Cu-HA-DPA-Van微球材料,采用菌落计数法评价材料对金黄色葡萄球菌的抗菌效果。 成功合成各种Cu-HA,随着Cu比例的增加,其形貌从条带状逐渐变成均匀球状,其中摩尔掺杂比例为10%的Cu-HA显示良好的微球形状及表面花瓣状多孔微纳形貌。EDS及XRD分析表明材料主体结构依然为羟基磷灰石晶体且Cu已成功掺杂HA。傅里叶红外光谱仪显示PDA成功涂覆在材料表面。浸提液主要成分检测再次佐证Cu元素成功进入并替代部分HA中的Ca元素。10 mg/mLCu-HA-PDA-Van浸提液中含Van 0.27 mg/mL。体外细胞实验和成骨相关基因检测表明,Cu-HA-Van具有良好的生物活性和促骨分化作用。Cu-HA-PDA-Van微球最小抑菌浓度(minimum inhibitory concentration, MIC)为16 μg/mL,Cu-HA-Van微球相对于Cu-HA、HA-PDA和纯HA有显著和持久的抗菌效果。 利用Cu元素调控HA微观形貌、成功涂覆PDA并装载Van制备的Cu-HA-PDA-Van微球具有良好的抗菌性能和生物活性。
- 1 September 2021
- Vol. 52 (5) , 799-806
负载抗生素铜掺杂羟基磷灰石微球的制备及抗菌成骨评价
探讨负载万古霉素(vancomycin, Van)的铜(Cu)掺杂羟基磷灰石(hydroxyapatite, HA)微球制备方法,并于体外评价其抗菌及成骨作用。 采用水热合成法制备摩尔掺杂比例1%、5%、10%、20%的Cu掺杂HA微球(Cu-HA),通过扫描电镜观察其微观形貌变化,X射线衍射仪(X-ray diffractometer, XRD)研究其相组成并分析样品的结晶度。选择摩尔掺杂比例为10%的Cu-HA,利用X射线能谱仪(energy dispersive X-ray spectroscopy, EDS)分析样品的元素成分信息后,以聚多巴胺(polydopamine, PDA)为介质涂覆制备Cu-HA-PDA,采用XRD和傅里叶红外光谱仪检测样品涂覆效果。在Cu-HA-PDA装载Van,制备成Cu-HA-PDA-Van。将均为10 mg/mL的HA、Cu-HA、HA-PDA、Cu-HA-PDA-Van分别加入α培养基中制备各组浸提液,检测浸提液主要成分,检查Van质量浓度。探究材料浸提液对成骨前体细胞的毒性作用及骨髓间充质干细胞的增殖、分化作用,并检测成骨相关基因骨钙素(osteocalcin, OCN)、Runt相关转录因子2(runt-related transcription factor 2, RUNX-2)、碱性磷酸酶(alkaline phosphatase, ALP)表达。备好灭菌的HA、Cu-HA、HA-PDA、Cu-HA-PDA、Cu-HA-DPA-Van微球材料,采用菌落计数法评价材料对金黄色葡萄球菌的抗菌效果。 成功合成各种Cu-HA,随着Cu比例的增加,其形貌从条带状逐渐变成均匀球状,其中摩尔掺杂比例为10%的Cu-HA显示良好的微球形状及表面花瓣状多孔微纳形貌。EDS及XRD分析表明材料主体结构依然为羟基磷灰石晶体且Cu已成功掺杂HA。傅里叶红外光谱仪显示PDA成功涂覆在材料表面。浸提液主要成分检测再次佐证Cu元素成功进入并替代部分HA中的Ca元素。10 mg/mLCu-HA-PDA-Van浸提液中含Van 0.27 mg/mL。体外细胞实验和成骨相关基因检测表明,Cu-HA-Van具有良好的生物活性和促骨分化作用。Cu-HA-PDA-Van微球最小抑菌浓度(minimum inhibitory concentration, MIC)为16 μg/mL,Cu-HA-Van微球相对于Cu-HA、HA-PDA和纯HA有显著和持久的抗菌效果。 利用Cu元素调控HA微观形貌、成功涂覆PDA并装载Van制备的Cu-HA-PDA-Van微球具有良好的抗菌性能和生物活性。
- Open Access
- 7 May 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-8
Development of a valid Chinese version of the Cumberland Ankle Instability Tool in Chinese-speaking patients with chronic ankle instability disorders
As an effective scale for the condition assessment of patients with chronic ankle instability (CAI), the Cumberland Ankle Instability Tool (CAIT) is the most widely used scale, and its original version is written in English. Therefore, the purpose of our study is to apply the CAIT to Chinese patients and evaluate its responsiveness, reliability, and validity in terms of Chinese patients with CAI. First, we adapted the CAIT into the Chinese edition (CAIT-C), through which cross-cultural adaptation and translation can be carried out in a five-step procedure. Next, recruited patients completed the three periods of the Foot and Ankle Ability Measure (FAAM), CAIT-C, and the Medical Outcomes Study Short-Form 36 (SF-36) scales. Afterward, to assess the responsiveness, reliability, and validity, we calculated the standardized response mean (SRM), effect size (ES), Spearman's correlation coefficient (rs), minimal detectable change (MDC), standard error of measurement (SEM), intraclass correlation coefficient (ICC), and Cronbach’s alpha. Generally, in the use of CAI, 131, 119, and 86 patients favorably completed the three periods of the scales. The CAIT-C was proven to have good test–retest reliability (ICC = 0.930) and fine internal consistency (Cronbach’s alpha = 0.845–0.878). The low-value of MDC (0.04–2.28) and SEM (1.73) show it is possible to detect clinical changes when we take advantage of CAIT-C. Good or moderate correlations (rs = 0.422–0.738) were gained from the physical subscales of the SF-36 and the subscales of the FAAM and the CAIT-C. Fair or poor correlations (rs = 0.003–0.360) were gained between the mental subscales of the SF-36 and the CAIT-C, which sufficiently indicated that the CAIT-C had good validity. Moreover, good responsiveness was observed in the CAIT-C (ES = 1.316, SRM = 1.418). The CAIT-C scale is an effective, valid, and reliable tool to evaluate Chinese CAI patients.
- 7 May 2021
- Published by Springer Nature in Scientific Reports
- Vol. 11 (1) , 1-8
Open AccessDevelopment of a valid Chinese version of the Cumberland Ankle Instability Tool in Chinese-speaking patients with chronic ankle instability disorders
As an effective scale for the condition assessment of patients with chronic ankle instability (CAI), the Cumberland Ankle Instability Tool (CAIT) is the most widely used scale, and its original version is written in English. Therefore, the purpose of our study is to apply the CAIT to Chinese patients and evaluate its responsiveness, reliability, and validity in terms of Chinese patients with CAI. First, we adapted the CAIT into the Chinese edition (CAIT-C), through which cross-cultural adaptation and translation can be carried out in a five-step procedure. Next, recruited patients completed the three periods of the Foot and Ankle Ability Measure (FAAM), CAIT-C, and the Medical Outcomes Study Short-Form 36 (SF-36) scales. Afterward, to assess the responsiveness, reliability, and validity, we calculated the standardized response mean (SRM), effect size (ES), Spearman's correlation coefficient (rs), minimal detectable change (MDC), standard error of measurement (SEM), intraclass correlation coefficient (ICC), and Cronbach’s alpha. Generally, in the use of CAI, 131, 119, and 86 patients favorably completed the three periods of the scales. The CAIT-C was proven to have good test–retest reliability (ICC = 0.930) and fine internal consistency (Cronbach’s alpha = 0.845–0.878). The low-value of MDC (0.04–2.28) and SEM (1.73) show it is possible to detect clinical changes when we take advantage of CAIT-C. Good or moderate correlations (rs = 0.422–0.738) were gained from the physical subscales of the SF-36 and the subscales of the FAAM and the CAIT-C. Fair or poor correlations (rs = 0.003–0.360) were gained between the mental subscales of the SF-36 and the CAIT-C, which sufficiently indicated that the CAIT-C had good validity. Moreover, good responsiveness was observed in the CAIT-C (ES = 1.316, SRM = 1.418). The CAIT-C scale is an effective, valid, and reliable tool to evaluate Chinese CAI patients.
- Open Access
- 1 January 2021
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 26, 84-91
An animal model of early-stage femoral head osteonecrosis induced by cryo-insult in small tailed Han sheep
- 1 January 2021
- Published by Elsevier in Journal of Orthopaedic Translation
- Vol. 26, 84-91
Open AccessAn animal model of early-stage femoral head osteonecrosis induced by cryo-insult in small tailed Han sheep
- Open Access
- 25 May 2020
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 21 (1) , 1-11
Adaptation and psychometric evaluation of the simplified Chinese version of the identification of functional ankle instability questionnaire in Chinese-speaking patients with chronic ankle instability disorders
Background: The aims of this study were to adapt the Identification of Functional Ankle Instability (IdFAI) questionnaire into a simplified Chinese version and to assess its reliability, validity, and responsiveness in Chinese-speaking patients with chronic ankle instability (CAI) disorders. Methods: The simplified Chinese version of the IdFAI (SC-IdFAI) questionnaire was developed with a five-step procedure involving cross-cultural translation and adaptation. Three questionnaires, including the SC-IdFAI, Medical Outcomes Study Short-Form 36 (SF-36), and Foot and Ankle Ability Measure (FAAM), were administered to the recruited patients. Then, the Cronbach’s alpha value, intraclass correlation coefficient (ICC), standard error of measurement (SEM), minimal detectable change (MDC), Spearman’s correlation coefficient (rs), effect size (ES), and standardized response mean (SRM) were calculated to evaluate the reliability, validity, and responsiveness of the SC-IdFAI questionnaire. Results: A total of 131, 119, and 86 patients with CAI successfully completed the first, second, and third rounds of the questionnaires, respectively. Good or excellent internal consistency and test–retest reliability were found for the overall scale and subscales of the SC-IdFAI questionnaire. The values for the SEM (1.346) and MDC (3.73) were low, indicating that small clinical changes can be detected by the SC-IdFAI questionnaire. The correlations of the SC-IdFAI with FAAM and SF-36 were generally in agreement with the a priori hypotheses (85%, 34/40), suggesting the SC-IdFAI questionnaire has good construct validity. Moreover, the results suggest that the SC-IdFAI (ES = 1.123 and SRM = 1.554) has an acceptable level of responsiveness. Conclusion: The SC-IdFAI scale may be an effective tool, and it is responsive, reliable and valid for the assessment of Chinese patients suffering from CAI.
- 25 May 2020
- Published by Springer Nature in BMC Musculoskeletal Disorders
- Vol. 21 (1) , 1-11
Open AccessAdaptation and psychometric evaluation of the simplified Chinese version of the identification of functional ankle instability questionnaire in Chinese-speaking patients with chronic ankle instability disorders
Background: The aims of this study were to adapt the Identification of Functional Ankle Instability (IdFAI) questionnaire into a simplified Chinese version and to assess its reliability, validity, and responsiveness in Chinese-speaking patients with chronic ankle instability (CAI) disorders. Methods: The simplified Chinese version of the IdFAI (SC-IdFAI) questionnaire was developed with a five-step procedure involving cross-cultural translation and adaptation. Three questionnaires, including the SC-IdFAI, Medical Outcomes Study Short-Form 36 (SF-36), and Foot and Ankle Ability Measure (FAAM), were administered to the recruited patients. Then, the Cronbach’s alpha value, intraclass correlation coefficient (ICC), standard error of measurement (SEM), minimal detectable change (MDC), Spearman’s correlation coefficient (rs), effect size (ES), and standardized response mean (SRM) were calculated to evaluate the reliability, validity, and responsiveness of the SC-IdFAI questionnaire. Results: A total of 131, 119, and 86 patients with CAI successfully completed the first, second, and third rounds of the questionnaires, respectively. Good or excellent internal consistency and test–retest reliability were found for the overall scale and subscales of the SC-IdFAI questionnaire. The values for the SEM (1.346) and MDC (3.73) were low, indicating that small clinical changes can be detected by the SC-IdFAI questionnaire. The correlations of the SC-IdFAI with FAAM and SF-36 were generally in agreement with the a priori hypotheses (85%, 34/40), suggesting the SC-IdFAI questionnaire has good construct validity. Moreover, the results suggest that the SC-IdFAI (ES = 1.123 and SRM = 1.554) has an acceptable level of responsiveness. Conclusion: The SC-IdFAI scale may be an effective tool, and it is responsive, reliable and valid for the assessment of Chinese patients suffering from CAI.